179 related articles for article (PubMed ID: 12306724)
1. Mini-pill approved by FDA.
IPPF Med Bull; 1973 Jun; 7(3):3. PubMed ID: 12306724
[TBL] [Abstract][Full Text] [Related]
2. Second FDA report on the pill.
IPPF Med Bull; 1970; 4(1):4. PubMed ID: 12255090
[TBL] [Abstract][Full Text] [Related]
3. FDA opens door for emergency contraception.
Landovitz K
AVSC News; 1997; 35(2):7. PubMed ID: 12294488
[TBL] [Abstract][Full Text] [Related]
4. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
5. [Advantage of low-dose oral contraception].
Rozenbaum H
Contracept Fertil Sex (Paris); 1973 Sep; 1(1):19-20. PubMed ID: 12276840
[TBL] [Abstract][Full Text] [Related]
6. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
8. Officials say dispensing ECPs will not endanger Title X clinics.
Contracept Technol Update; 1993 Mar; 14(3):39-40. PubMed ID: 12318084
[TBL] [Abstract][Full Text] [Related]
9. The pill: is low estrogen the answer?
Peck RL
Curr Prescr; 1976 Sep; 2(9):19. PubMed ID: 12229573
[TBL] [Abstract][Full Text] [Related]
10. FDA panel examines link between breast cancer, pill, says more research needed.
Wash Memo Alan Guttmacher Inst; 1989 Jan; ():3-4. PubMed ID: 12283353
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of biphasic and triphasic pills.
Cohen J
IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
[TBL] [Abstract][Full Text] [Related]
13. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
15. Ortho markets first FDA-approved triphasic pill.
Contracept Technol Update; 1984 Jun; 5(6):69-71. PubMed ID: 12313082
[TBL] [Abstract][Full Text] [Related]
16. Labeling emergency contraception.
Wash Memo Alan Guttmacher Inst; 1994 Dec; ():6. PubMed ID: 12288098
[TBL] [Abstract][Full Text] [Related]
17. Vaginal contraceptives merge old forms, new data.
Contracept Technol Update; 1983 Jul; 4(7):73-5. PubMed ID: 12339358
[TBL] [Abstract][Full Text] [Related]
18. An update on the pill.
Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
[TBL] [Abstract][Full Text] [Related]
19. Norplant implant now a step closer to U.S. use.
Haupt A
Popul Today; 1989; 17(7-8):4. PubMed ID: 12282121
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and venous thromboembolism: consensus conference statement.
Dialogues in Contraception Consensus Conference (1995: Chicago)
Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
